MMSI — Merit Medical Systems Share Price
0.000.00%
Last trade - 00:00- $5.59bn
- $5.93bn
- $1.36bn
- 92
- 26
- 80
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.62 | ||
| PEG Ratio (f) | 0.94 | ||
| EPS Growth (f) | 39.62% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.91 | ||
| Price to Tang. Book | 11.53 | ||
| Price to Free Cashflow | 31.39 | ||
| Price to Sales | 4.03 | ||
| EV to EBITDA | 21.08 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.08% | ||
| Return on Equity | 9.16% | ||
| Operating Margin | 11.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 963.88 | 1,074.75 | 1,150.98 | 1,257.37 | 1,356.51 | 1,480.55 | 1,570.77 | 6.4% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -12.82 | +125.52 | +34.92 | +19.17 | +24.62 | +59.17 | +13.26 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Merit Medical Systems, Inc. is engaged in manufacturing and marketing of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in various clinical areas, such as radiology, electrophysiology, and more.
Directors
- Fred Lampropoulos CHM (71)
- Raul Parra CFO (43)
- Joseph Wright CEX (51)
- Ronald Frost COO (59)
- Michel Voigt CHO (48)
- Robert Fredericks OTH (48)
- Brian Lloyd SEC (60)
- Stephen Evans DRC
- A. Scott Anderson IND (74)
- Jill Anderson IND (61)
- Lonny Carpenter IND (59)
- David Floyd IND (60)
- Thomas Gunderson IND (70)
- James Hogan IND (64)
- F. Ann Millner IND (69)
- Lynne Ward IND (62)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- July 28th, 1987
- Public Since
- September 16th, 1954
- No. of Shareholders
- 90
- No. of Employees
- 7,400
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 59,099,536
- Address
- 1600 West Merit Park Way, SOUTH JORDAN, 84095
- Web
- https://www.merit.com/
- Phone
- +1 8012531600
- Contact
- Mike Piccinino
- Auditors
- Deloitte & Touche LLP
Upcoming Events for MMSI
Merit Medical Systems Inc Annual Shareholders Meeting
Q2 2025 Merit Medical Systems Inc Earnings Release
Similar to MMSI
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Merit Medical Systems share price?
As of Today at 22:00 UTC, shares in Merit Medical Systems are trading at $94.61. This share price information is delayed by 15 minutes.
How has the Merit Medical Systems share price performed this year?
Shares in Merit Medical Systems last closed at $94.61 and the price had moved by +28.93% over the past 365 days. In terms of relative price strength the Merit Medical Systems share price has outperformed the S&P500 Index by +19.01% over the past year.
What are the analyst and broker recommendations for Merit Medical Systems?
The overall consensus recommendation for Merit Medical Systems is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Merit Medical Systems dividend yield?
Merit Medical Systems does not currently pay a dividend.
Does Merit Medical Systems pay a dividend?
Merit Medical Systems does not currently pay a dividend.
When does Merit Medical Systems next pay dividends?
Merit Medical Systems does not currently pay a dividend.
How do I buy Merit Medical Systems shares?
To buy shares in Merit Medical Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Merit Medical Systems?
As of the previous close price of $94.61, shares in Merit Medical Systems had a market capitalisation of $5.59bn.
Where are Merit Medical Systems shares listed?
Here are the trading details for Merit Medical Systems:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: MMSI
What kind of share is Merit Medical Systems?
Based on an overall assessment of its quality, value and momentum Merit Medical Systems is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Merit Medical Systems share price forecast for 2025?
The analyst consensus target price for shares in Merit Medical Systems is $107.10. That is 13.2% above the last closing price of $94.61.
Analysts covering Merit Medical Systems currently have a consensus Earnings Per Share (EPS) forecast of $3.41 for the next financial year.
Find out moreWhat is the trend in the Merit Medical Systems share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Merit Medical Systems. Over the past six months, its share price has outperformed the S&P500 Index by +3.87%.
As of the last closing price of $94.61, shares in Merit Medical Systems were trading -3.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Merit Medical Systems PE Ratio?
The Merit Medical Systems PE ratio based on its reported earnings over the past 12 months is 26.62. The shares last closed at $94.61.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Merit Medical Systems?
Merit Medical Systems' management team is headed by:
- Fred Lampropoulos - CHM
- Raul Parra - CFO
- Joseph Wright - CEX
- Ronald Frost - COO
- Michel Voigt - CHO
- Robert Fredericks - OTH
- Brian Lloyd - SEC
- Stephen Evans - DRC
- A. Scott Anderson - IND
- Jill Anderson - IND
- Lonny Carpenter - IND
- David Floyd - IND
- Thomas Gunderson - IND
- James Hogan - IND
- F. Ann Millner - IND
- Lynne Ward - IND